|
Re: Possibility?
|
4
|
Resverlogix Corp.
|
May 07, 2024 09:44AM
|
|
Re: Canadian Securities Administrators
|
4
|
Resverlogix Corp.
|
May 18, 2024 02:37PM
|
|
Re: Additional Reports Of Exempt Distribution.
|
3
|
Zenith Epigenetics
|
Jun 06, 2024 10:11AM
|
|
Re: A Special Meeting of Shareholders?
|
4
|
Resverlogix Corp.
|
Jun 06, 2024 10:21AM
|
|
Re: Additional Reports Of Exempt Distribution.
|
2
|
Zenith Epigenetics
|
Jun 07, 2024 11:10AM
|
|
While we wait…
|
4
|
Resverlogix Corp.
|
Jun 14, 2024 10:31AM
|
|
Re: if the partial sale of zen
|
9
|
Resverlogix Corp.
|
Aug 02, 2024 07:39PM
|
|
Re: if the partial sale of zen
|
8
|
Resverlogix Corp.
|
Aug 08, 2024 02:14AM
|
|
Re: Anonymous seller
|
5
|
Resverlogix Corp.
|
Aug 08, 2024 02:24AM
|
|
Re: One More Promissory Note-Aug 9/24
|
7
|
Zenith Epigenetics
|
Aug 21, 2024 11:23AM
|
|
Re: Hypothetical thought
|
6
|
Zenith Epigenetics
|
Aug 21, 2024 11:43AM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 21, 2024 11:45AM
|
|
Re: Narmac
|
6
|
Resverlogix Corp.
|
Aug 21, 2024 11:50AM
|
|
Trading
|
5
|
Resverlogix Corp.
|
Aug 21, 2024 11:59AM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
8
|
Zenith Epigenetics
|
Sep 26, 2024 03:01PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
7
|
Zenith Epigenetics
|
Sep 27, 2024 03:10PM
|
